Skip to content

Comparison of the effectiveness of metacognitive therapy and Barlow meta-diagnosis in cognitive emotion regulation, experiential avoidance and reduction of clinical symptoms in the treatment of patients with anxiety disorder

Comparison of the effectiveness of metacognitive therapy and Barlow meta-diagnosis in cognitive emotion regulation, experiential avoidance and reduction of clinical symptoms in the treatment of patients with anxiety disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220420054593N1
Enrollment
45
Registered
2022-06-15
Start date
2021-08-23
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

generalized anxiety disorder. Generalized anxiety disorder

Interventions

Intervention group: The effectiveness of Barlow metacognitive therapy and meta-diagnostic therapy in cognitive emotion regulation, experiential avoidance and reduction of clinical symptoms in the trea

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The research method is quasi-experimental with pre-test and post-test design and the statistical population of the study included patients with clinical symptoms of generalized anxiety disorder who referred to counseling and psychological clinics in Mashhad.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Generalized Anxiety Disorder In this study, Symptoms of Anxiety Disorders Using the Adult Version of the Anxiety Disorders Interview Program for DSM-5 (ADIS-5) Brown & Barlow, 2014), Adult Version of the Pediatric Anxiety Disorders Screening Questionnaire (SCARED) -A) Van Steinsel Weblogs, 2014); The Beck Anxiety Inventory (Beck, Epstein, Brown, & Steer, 1993), the Social Interaction Anxiety Scale (SIAS; Metic & Clark, 1998), and the Comprehensive Anxiety Disorder Short Scale (Spitzer, Kronki, Williams, & Brand, 2006) are measured. Timepoint: Anxiety questionnaires are collected from clients in the first week of treatment and in the following weeks every two weeks. Method of measurement: Anxiety Assessment Questionnaires.

Secondary

MeasureTime frame
Emotion regulation: is the score that a person obtains in the difficult questionnaire in emotion regulation Graz and Roemer (2004). Timepoint: The first week and once every two weeks. Method of measurement: emotion regulation Graz and Roemer.;Experimental Avoidance: The score that a person obtains in the Experiential Avoidance Questionnaire of the Acceptance and Editing Practice Questionnaire (AAQ-II). Timepoint: The first week and once every two weeks in subsequent weeks. Method of measurement: the Acceptance and Editing Practice Questionnaire (AAQ-II).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Taheri

Mashhad University of Medical Sciences

taheriem@mums.ac.ir+98 51 3711 2709

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026